Pharmaceutical Composition for Preventing or Treating Chronic Graft-Versus-Disease Comprising Anti-CD137 Monoclonal Antibody
AssigneeUniversity of Ulsan Foundation for Industry Cooperation
InventorsByung Suk Kwon, Ju Yang Kim, Hong Rae Cho
Life of this patent
Estimating the term…
Abstract
Provided is a pharmaceutical composition for preventing and treating chronic graft-versus-host disease (cGVHD) containing an anti-CD137 monoclonal antibody. The pharmaceutical composition containing the anti-CD137 monoclonal antibody as an active component reduces a cytokine produced from a CD4+ T cell, and increases a death of a donor CD4+ T cell, thereby effectively preventing and treating cGVHD, and thus can be useful for allogeneic stem cell transplantation.
Claims3
A pharmaceutical composition for preventing and treating chronic graft-versus-host disease (cGVHD) comprising an anti-CD137 monoclonal antibody as an active component.
Dependencies are inferred from the claim text.